High Prevalence of Multi-Drug Resistance and Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae Among Hospitalized Patients Presumptive for Bacterial Infection at Debre Berhan Comprehensive Specialized Hospital, Ethiopia

References

• Nordmann P, Dortet L, Poirel L. Carbapenem resistance in Enterobacteriaceae. Trend Mol Med. 2012;18(5):263–272. doi:10.1016/j.molmed.2012.03.003
   PubMed Web of Science ®Google Scholar
• World Health Organization. Antimicrobial resistance: global report on surveillance: World Health Organization; 2014. Available from: https://apps.who.int/iris/bitstream/10665/112642/1/9789241564748_eng.pdf. Accessed May 19, 2022.
   Google Scholar
• Andrew B, Kagirita A, Bazira J. Prevalence of extended-spectrum beta-lactamases-producing microorganisms in patients admitted at KRRH, Southwestern Uganda. Int J Microbiol. 2017;2017. doi:10.1155/2017/3183076
   Web of Science ®Google Scholar
• Mohamudha PR, Harish B, Parija S. AmpC beta lactamases among Gram negative clinical isolates from a tertiary hospital, South India. Braz J Microbiol. 2010;41(3):596–602. doi:10.1590/S1517-83822010000300009
   Web of Science ®Google Scholar
• Rawat D, Nair D. Extended-spectrum β-lactamases in gram negative bacteria. J Glob Infect Dis. 2010;2(3):263. doi:10.4103/0974-777X.68531
   PubMedGoogle Scholar
• Schwaber MJ, Navon-Venezia S, Schwartz D, Carmeli Y. High levels of antimicrobial coresistance among extended-spectrum-β-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother. 2005;49(5):2137. doi:10.1128/AAC.49.5.2137-2139.2005
   PubMed Web of Science ®Google Scholar
• Livermore D. Beta-lactamase-mediated resistance and opportunities for its control. J Antimicrob Chemother. 1998;41(suppl_4):25–41. doi:10.1093/jac/41.suppl_4.25
   Web of Science ®Google Scholar
• Kariuki S, Dougan G. Antibacterial resistance in sub-Saharan Africa: an underestimated emergency. Ann N Y Acad Sci. 2014;1323(1):43. doi:10.1111/nyas.12380
   PubMed Web of Science ®Google Scholar
• Ampaire L, Muhindo A, Orikiriza P, Mwanga-Amumpaire J, Boum Y, Bebell L. A review of antimicrobial resistance in East Africa. Afr J Lab Med. 2016;5(1):1–6. doi:10.4102/ajlm.v5i1.432
   Google Scholar
• Legese MH, Weldearegay GM, Asrat D. Extended-spectrum beta-lactamase-and carbapenemase-producing Enterobacteriaceae among Ethiopian children. Infect Drug Resist. 2017;10:27. doi:10.2147/IDR.S127177
   PubMed Web of Science ®Google Scholar
• Moges F, Eshetie S, Abebe W, et al. High prevalence of extended-spectrum beta-lactamase-producing Gram-negative pathogens from patients attending Felege Hiwot Comprehensive Specialized Hospital, Bahir Dar, Amhara region. PLoS One. 2019;14(4):e0215177. doi:10.1371/journal.pone.0215177
   PubMed Web of Science ®Google Scholar
• Ethiopia FDRo. 2007 Population and housing census of Ethiopia. (Administrative Report). Central Statistical Authority Addis Ababa; 2012.
   Google Scholar
• Mulisa G, Selassie L, Jarso G, et al. Prevalence of extended spectrum beta-lactamase producing Enterobacteriaceae: a cross sectional study at Adama Hospital, Adama, Ethiopia. J Emerg Infect Dis. 2016;1(1):1–6.
   Google Scholar
• Wayne P. Clinical and Laboratory Standards Institute. In: Performance Standards for Antimicrobial Susceptibility Testing; 2011.
   Google Scholar
• Eshetie S, Gelaw A, Ayelign B, Endris M, Moges F. Multidrug resistant and carbapenemase producing Enterobacteriaceae among patients with urinary tract infection at referral hospital, Northwest Ethiopia. Antimicrob Resist Infect Control. 2015;4(1):12. doi:10.1186/s13756-015-0054-7
   Web of Science ®Google Scholar
• Dahab R, Ibrahim AM, Altayb HN. Phenotypic and genotypic detection of carbapenemase enzymes producing gram-negative bacilli isolated from patients in Khartoum State. F1000Research. 2017;6(1656):1656. doi:10.12688/f1000research.12432.1
   Google Scholar
• Kateregga JN, Kantume R, Atuhaire C, Lubowa MN, Ndukui JG. Phenotypic expression and prevalence of ESBL-producing Enterobacteriaceae in samples collected from patients in various wards of Mulago Hospital, Uganda. BMC Pharmacol Toxicol. 2015;16(1):1–6. doi:10.1186/s40360-015-0013-1
   Web of Science ®Google Scholar
• Kajeguka DC, Kabissi F, Kamugisha B, et al. Antimicrobial resistance patterns of phenotype extended spectrum beta-lactamase producing bacterial isolates in a referral hospital in northern Tanzania. Tanzan J Health Res. 2015;17(3). doi:10.4314/thrb.v17i3.2.
   Google Scholar
• Tekele SG, Teklu DS, Tullu KD, Birru SK, Legese MH. Extended-spectrum beta-lactamase and AmpC beta-lactamases producing gram negative bacilli isolated from clinical specimens at International Clinical Laboratories, Addis Ababa, Ethiopia. PLoS One. 2020;15(11):e0241984. doi:10.1371/journal.pone.0241984
   Web of Science ®Google Scholar
• Teklu DS, Negeri AA, Legese MH, Bedada TL, Woldemariam HK, Tullu KD. Extended-spectrum beta-lactamase production and multi-drug resistance among Enterobacteriaceae isolated in Addis Ababa, Ethiopia. Antimicrob Resist Infect Control. 2019;8(1):1–12. doi:10.1186/s13756-019-0488-4
   Web of Science ®Google Scholar
• Abera B, Kibret M, Mulu W. Extended-spectrum beta (β)-lactamases and antibiogram in Enterobacteriaceae from clinical and drinking water sources from Bahir Dar City, Ethiopia. PLoS One. 2016;11(11):e0166519. doi:10.1371/journal.pone.0166519
   PubMed Web of Science ®Google Scholar
• Zeynudin A, Pritsch M, Schubert S, et al. Prevalence and antibiotic susceptibility pattern of CTX-M type extended-spectrum β-lactamases among clinical isolates of gram-negative bacilli in Jimma, Ethiopia. BMC Infect Dis. 2018;18(1):1–10. doi:10.1186/s12879-018-3436-7
   Web of Science ®Google Scholar
• Ouedraogo A-S, Sanou M, Kissou A, et al. High prevalence of extended-spectrum ß-lactamase producing Enterobacteriaceae among clinical isolates in Burkina Faso. BMC Infect Dis. 2016;16(1):1–9. doi:10.1186/s12879-016-1655-3
   Web of Science ®Google Scholar
• Babu R, Kumar A, Karim S, et al. Faecal carriage rate of extended-spectrum β-lactamase-producing Enterobacteriaceae in hospitalised patients and healthy asymptomatic individuals coming for health check-up. J Glob Antimicrob Res. 2016;6:150–153. doi:10.1016/j.jgar.2016.05.007
   Web of Science ®Google Scholar
• Siraj SM, Ali S, Wondafrash B. Extended-spectrum β-lactamase production in Klebsiella pneumoniae and Escherichia coli at Jimma University Specialized Hospital, south-west, Ethiopia. Mol Microbiol Res. 2015;5. doi:10.1186/s13756-019-0488-4
   Google Scholar
• Nepal K, Pant ND, Neupane B, et al. Extended spectrum beta-lactamase and metallo beta-lactamase production among Escherichia coli and Klebsiella pneumoniae isolated from different clinical samples in a tertiary care hospital in Kathmandu, Nepal. Ann Clin Microbiol Antimicrob. 2017;16(1):1–7. doi:10.1186/s12941-017-0236-7
   Web of Science ®Google Scholar
• Aklilu A, Manilal A, Ameya G, Woldemariam M, Siraj M. Gastrointestinal tract colonization rate of extended-spectrum beta-lactamase-and carbapenemase-producing Enterobacteriaceae and associated factors among hospitalized patients in Arba Minch General Hospital, Arba Minch, Ethiopia. Infect Drug Resist. 2020;13:1517. doi:10.2147/IDR.S239092
   PubMed Web of Science ®Google Scholar
• Kibwana UO, Majigo M, Kamori D, Manyahi J. High fecal carriage of extended beta lactamase producing Enterobacteriaceae among adult patients admitted in referral hospitals in Dar es Salaam, Tanzania. BMC Infect Dis. 2020;20(1):1–7.
   Web of Science ®Google Scholar
• Bayleyegn B, Fisaha R, Kasew D. Fecal carriage of extended spectrum beta-lactamase producing Enterobacteriaceae among HIV infected children at the University of Gondar Comprehensive Specialized Hospital Gondar, Ethiopia. AIDS Res Ther. 2021;18(1):1–9. doi:10.1186/s12981-021-00347-x
   Web of Science ®Google Scholar
• Arhoune B, Oumokhtar B, Hmami F, et al. Rectal carriage of extended-spectrum β-lactamase-and carbapenemase-producing Enterobacteriaceae among hospitalised neonates in a neonatal intensive care unit in Fez, Morocco. J Glob Antimicrob Res. 2017;8:90–96. doi:10.1016/j.jgar.2016.11.004
   Web of Science ®Google Scholar
• Mansouri S, Abbasi S. Prevalence of multiple drug resistant clinical isolates of extended-spectrum beta-lactamase producing Enterobacteriaceae in Southeast Iran; 2010.
   Google Scholar
• Mulu W, Abera B, Yimer M, Hailu T, Ayele H, Abate D. Bacterial agents and antibiotic resistance profiles of infections from different sites that occurred among patients at Debre Markos Referral Hospital, Ethiopia: a cross-sectional study. BMC research notes. 2017;10(1):1-9.
   Google Scholar
• Moges F, Mengistu G, Genetu A. Multiple drug resistance in urinary pathogens at Gondar College of Medical science hospital, Ethiopia. East Afr Med J. 2002;79(8):415–420. doi:10.4314/eamj.v79i8.8827
   Google Scholar
• Seni J, Sweya E, Mabewa A, Mshana SE, Gilyoma JM. Comparison of antimicrobial resistance patterns of ESBL and non ESBL bacterial isolates among patients with secondary peritonitis at Bugando Medical Centre, Mwanza–Tanzania. BMC Emerg Med. 2016;16(1):1–5. doi:10.1186/s12873-016-0106-1
   Google Scholar
• Alemu A, Dagnew M, Alem M, Gizachew M. Uropathogenic bacterial isolates and their antimicrobial susceptibility patterns among HIV/AIDS patients attending Gondar University Specialized Hospital Gondar, Northwest Ethiopia; 2013.
   Google Scholar
• Biadglegne F, Abera B. Antimicrobial resistance of bacterial isolates from urinary tract infections at Felege Hiwot Referral Hospital, Ethiopia. Ethiop J Health Dev. 2009;23(3):236–238.
   Web of Science ®Google Scholar
• Kibret M, Abera B. Antimicrobial susceptibility patterns of E. coli from clinical sources in northeast Ethiopia. Afr Health Sci. 2011;11(3):40–45. doi:10.4314/ahs.v11i3.70069
   Google Scholar
• Magale H, Kassim I, Odera S, Omolo M, Jaoko W, Jolly P. Antibiotic susceptibility of organisms causing urinary tract infection in patients presenting at Kenyatta National Hospital, Nairobi. East Afr Med J. 2015;92(7):333–337.
   Google Scholar
• Ruh E, Hoti K, Fekrat A, et al. Extended-spectrum β-lactamase, plasmid-mediated AmpC β-lactamase, fluoroquinolone resistance, and decreased susceptibility to carbapenems in Enterobacteriaceae: fecal carriage rates and associated risk factors in the community of Northern Cyprus. Antimicrob Resist Infect Cont. 2019;8(1):1–10.
   Web of Science ®Google Scholar
• Medboua-Benbalagh C, Touati A, Kermas R, et al. Fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae strains is associated with worse outcome in patients hospitalized in the pediatric oncology unit of Beni-Messous hospital in Algiers, Algeria. Microbial Drug Res. 2017;23(6):757–763. doi:10.1089/mdr.2016.0153
   Web of Science ®Google Scholar
• Norouzi F, Hasanvand F, Nojoomi F. Risk factors associated with ESBL and CPE acquisition among‎ pediatrics: a systematic review. Infect Epidemiol Microbiol. 2018;4(1):35–40.
   Google Scholar
• Sharif MR, Soltani B, Moravveji A, Erami M, Soltani N. Prevalence and risk factors associated with extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae isolates in hospitalized patients in Kashan (Iran). Electron Physician. 2016;8(3):2081. doi:10.19082/2081
   Google Scholar
• Sangare SA, Maataoui N, Maiga AI, et al. Very high prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in bacteremic patients hospitalized in teaching hospitals in Bamako, Mali. PLoS One. 2017;12(2):e0172652. doi:10.1371/journal.pone.0172652
   Web of Science ®Google Scholar